Drag a card by its title · ⚙ to size, swap or remove

The company

uniQure N.V. -

QURE · Nasdaq

Health CareBiotechnologyNot moving yet

QURE stood above a rising 150-day average in 19 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 32.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 3
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $42.1M
Officials’ trades on record: 0
Institutions holding: 245 (+40)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 19 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months37

Buyers · sellers0 · 12

Who	Did	Shares	Traded
Matthew C. KapustaCEO, Managing Director	sold	9,200at $44.43	2 Jul 2026filed 7 Jul 2026
Matthew C. KapustaCEO, Managing Director	sold	4,282at $45.43	2 Jul 2026filed 7 Jul 2026
Matthew C. KapustaCEO, Managing Director	sold	7,600at $45.89	2 Jul 2026filed 7 Jul 2026
Jack KayeDirector	sold	4,107at $46.49	30 Jun 2026filed 2 Jul 2026
Jack KayeDirector	sold	17,060at $46.43	30 Jun 2026filed 2 Jul 2026
Walid Abi-SaabChief Medical Officer	sold	10,000at $46.46	30 Jun 2026filed 2 Jul 2026
Walid Abi-SaabChief Medical Officer	sold	20,000at $46.40	30 Jun 2026filed 2 Jul 2026
Walid Abi-SaabChief Medical Officer	sold	1,434at $46.86	26 Jun 2026filed 30 Jun 2026
Matthew C. KapustaCEO, Managing Director	sold	28,716at $50.02	25 Jun 2026filed 26 Jun 2026
Matthew C. KapustaCEO, Managing Director	sold	6,696at $50.00	24 Jun 2026filed 26 Jun 2026
Matthew C. KapustaCEO, Managing Director	sold	4,656at $50.00	18 Jun 2026filed 22 Jun 2026
Matthew C. KapustaCEO, Managing Director	sold	37,015at $50.00	18 Jun 2026filed 22 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders245+40 on the quarter

New · exited87 · 46

Reported value$3.0B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Avoro Capital Advisors LLCadded · filed 14 Aug 2026	6,727,777$309.9M	+768,182+12.9%
JPMORGAN CHASE & COnew · filed 12 Aug 2026	4,867,755$230.8M	+4,867,755
RTW INVESTMENTS, LPadded · filed 14 Aug 2026	3,941,572$181.5M	+1,355,216+52.4%
STATE STREET CORPadded · filed 7 Aug 2026	2,903,825$133.8M	+643,313+28.5%
Aberdeen Group plcreduced · filed 31 Jul 2026	2,848,117$131.2M	-2,458,269−46.3%
BlackRock, Inc.added · filed 7 Aug 2026	1,877,453$86.5M	+143,995+8.3%
ORBIMED ADVISORS LLCreduced · filed 14 Aug 2026	1,807,486$83.3M	-328,663−15.4%
JANE STREET GROUP, LLCadded · filed 14 Aug 2026	1,610,483$74.2M	+974,488+153.2%
JENNISON ASSOCIATES LLCadded · filed 3 Aug 2026	1,561,412$71.9M	+327,623+26.6%
Boxer Capital Management, LLCadded · filed 14 Aug 2026	1,503,300$69.2M	+841,300+127.1%